Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,266
datasets available to search
ShareScore release 0.9.0
Dataset results
3,266 results for “Combination therapy”
An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy
ClinicalTrials.gov study NCT00193947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
ClinicalTrials.gov study NCT00095550. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
ClinicalTrials.gov study NCT00234637. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT03308201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
ClinicalTrials.gov study NCT03249519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
McNeill Dysphagia Therapy Program Combined With Transcranial Magnetic Stimulation
ClinicalTrials.gov study NCT06184711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)
ClinicalTrials.gov study NCT02767063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eravacycline Combination Therapy for MRAB
ClinicalTrials.gov study NCT06282835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Cli
ClinicalTrials.gov study NCT07004335. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
ClinicalTrials.gov study NCT05896059. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand
ClinicalTrials.gov study NCT01659281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
ClinicalTrials.gov study NCT05777707. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Goal-directed Algorithms of Hemodynamic Therapy After Combined Valve Repair
ClinicalTrials.gov study NCT01276444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer
ClinicalTrials.gov study NCT07386938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
ClinicalTrials.gov study NCT06711068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT03063762. IPD Sharing: Not stated. Countries: 9. Publications: 0.
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI
ClinicalTrials.gov study NCT02381405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
ClinicalTrials.gov study NCT01625494. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX
ClinicalTrials.gov study NCT01395667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
ClinicalTrials.gov study NCT07198633. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.